Effect of selection cell density on the recovery of mutagen-induced 6-thioguanine-resistant cells (CHO/HGPRT system). 1982

J P O'Neill, and K O Bowman

The relationship between the cell density utilized in the selection for 6-thioguanine-resistant mutants induced by ethyl methanesulfonate and the recovery of mutant colonies was determined in Chinese hamster ovary cells. After an adequate phenotypic expression time of 9 days post mutagen treatment, cultures were plated in selection medium at cell densities ranging from 5 X 10(4) to 2 X 10(6) cells/100 mm dish (0.9 to 36.0 X 10(3) cells/cm2). A decline in the frequency of mutant colonies was observed with increasing cell density, and analysis of the data showed that the loss was independent of the frequency of mutants in the cell population. This loss occurred in an exponential fashion, consistent with a random-target effect. Regression analysis of the data points yielded a best-fit line defined by the equation log(y) = 2.01 - 0.26(10(-6) ) x, where y = percentage recovery and x = selection cell density (cells per 100 mm dish). This study defines the cell density-dependent loss of mutants under selection conditions, and provides a basis for further study of the influence of agents on cell contact-mediated crossfeeding and possible effects on mutation induction determinations. These results also demonstrate the importance of the use of appropriate cell densities in mutant selections.

UI MeSH Term Description Entries
D007041 Hypoxanthine Phosphoribosyltransferase An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or MERCAPTOPURINE to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8. Guanine Phosphoribosyltransferase,HPRT,Hypoxanthine-Guanine Phosphoribosyltransferase,IMP Pyrophosphorylase,HGPRT,HPRTase,Hypoxanthine Guanine Phosphoribosyltransferase,Phosphoribosyltransferase, Guanine,Phosphoribosyltransferase, Hypoxanthine,Phosphoribosyltransferase, Hypoxanthine-Guanine,Pyrophosphorylase, IMP
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females

Related Publications

J P O'Neill, and K O Bowman
January 1980, Radiation research,
J P O'Neill, and K O Bowman
October 1981, Experimental cell research,
J P O'Neill, and K O Bowman
October 1981, Food and cosmetics toxicology,
Copied contents to your clipboard!